Genetic Diversity of HIV-1 and Transfusion Safety : Systematic Review and Concepts Analysis
International STD Research & Reviews,
Background: The genetic diversity of human immunodeficiency virus type 1 (HIV-1) is a real problem facing blood banks. This genetic diversity has a negative impact on diagnostic strategies within the transfusion chain by weakening the security of the donation. The objective of this study is to clarify the concepts emanating from the research project entitled : «Genetic diversity of HIV-1 and its effect on the residual risk in blood transfusion in Gabon».
Methods: This study was the result of a systematic review and a conceptual analysis of several studies that were systematically searched for in databases (PubMed, Google Scholar, and Medline), and whose object was focused on the genetic diversity of HIV -1 and its impact on transfusion safety. Indeed, the information relating to the concepts coming from the full articles was used. These were obtained by reading the most relevant articles. All relevant studies reporting data on HIV-1 genetic diversity and blood safety published in English between January 2012 and December 2020 have been identified for context. The method of conceptual analysis of « Walker and Avant (2005) » was used to clarify the different concepts of our study. The correlation test was used to show the relationship between the concepts.
Results: This systematic review and conceptual analysis study made it possible to determine the variables and to clarify the different concepts (HIV-1, Genetic diversity, Blood transfusion, Residual risk) essential for carrying out our research project entitled: "Genetic diversity of HIV-1 and its effect on the residual risk in blood transfusion". This model made it possible to show the effect of the genetic diversity of HIV-1 on the residual risk in blood transfusion using as model variables : viral load and serological markers (Antibodies and P24 Antigen). Knowledge of molecular strains (URF, CRF, subtypes) during this study made it possible to better identify the molecular strains most involved in the residual risk. Despite its complexity, this conceptual analysis contributed enormously to the understanding of the activities and the quantifiable and non-quantifiable components that participated in our study. Statistical analysis showed that the HIV-1 concept was significantly related to the other three concepts with P = 0.001. Likewise for the concept of genetic diversity was also significantly linked to the two other concepts with P = 0.003.
Conclusion: The genetic diversity of HIV-1 in the blood transfusion environment contributes significantly to the transmission of HIV from donor to recipient. The mastery of these molecular strains is essential for the various blood banks to ensure a safe blood supply.
- blood transfusion
- genetic diversity
- residual risk
How to Cite
World Health Organization. VIH/ SIDA : Recommandations. I recovered the web on June 10 ; 2021.
Rupp S, Ambata P, Narat V, Giles-Vernick T. Beyond the cut hunter: A historical epidemiology of HIV beginnings in Central Africa. EcoHealth [Internet]. Springer Science and Business Media LLC. 2016; 13(4):661–71.
Bes M, Piron M, Casamitjana N, Gregori J, Esteban JI, Ribera E, et al. Epidemiological trends of HIV-1 infection in blood donors from Catalonia, Spain (2005-2014). Transfusion [Internet]. Wiley. 2017 Jul 5;57(9):2164–73.
Seck M, Dièye B, Guèye YB, Faye BF, Senghor AB, Toure SA, et al. Évaluation de l’efficacité de la sélection médicale des donneurs de sang dans la prévention des agents infectieux. Transfusion Clinique et Biologique [Internet]. Elsevier BV. 2016;23(2):98–102. DOI :10.1016/j.tracli.2015.11.001
Jacquot C, Delaney M. Efforts toward elimination of infectious agents in blood products. Journal of Intensive Care Medicine [Internet]. SAGE Publications; 2018 ;33(10):543–50.
Morar MM, Pitman JP, McFarland W, Bloch EM. The contribution of unsafe blood transfusion to human immunodeficiency virus incidence in sub-Saharan Africa: reexamination of the 5% to 10% convention. Transfusion [Internet]. Wiley. 2016;56(12):3121–32. DOI :10.1111/trf.13816
Police SMC, Bessanguem B, Mofini E, Elowa B, Service G, Guéréndo P, et al. High prevalence of hepatitis B virus infection compared to human immunodeficiency virus among blood donors in Bangui. Open Journal of Gastroenterology [Internet]. Scientific Research Publishing, Inc. 2020;10(06):137–43.
Ajugwo AO, Erhabor TA, Eledo BO, Eze RI, Digban KA. Prevalence of transfusion transmissible infections in a Nigerian Tertiary Hospital. Journal of Transmitted Diseases and Immunity [Internet]. Scitechnol Biosoft Pvt. Ltd. 2017;01(02).
Pessôa R, Loureiro P, Esther Lopes M, Carneiro-Proietti ABF, Sabino EC, Busch MP, et al. Ultra-deep sequencing of HIV-1 near full-length and partial proviral genomes reveals high genetic diversity among brazilian blood donors. Kaderali L, editor. PLOS ONE [Internet]. Public Library of Science (PLoS). 2016 Mar 31;11(3):e0152499.
Zhao J, Lv X, Chang L, Ji H, Harris BJ, Zhang L, et al. HIV-1 molecular epidemiology and drug resistance-associated mutations among treatment-naïve blood donors in China. Scientific Reports [Internet]. Springer Science and Business Media LLC. 2020;10(1). DOI:10.1038/s41598-020-64463-w
Page MJ, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow CD, et al. Updating guidance for reporting systematic reviews : Development of the PRISMA 2020 statement. Center for Open Science; 2020. DOI :org/10.31222/osf.io/jb4dx.
Tetzlaff J, Page M, Moher D. PNS154 the prisma 2020 statement : development of and key changes in an updated guideline for reporting systematic reviews and meta-analyses. value in health [internet]. Elsevier bv. 2020;23:S312-S313.
Renz SM, Carrington JM, Badger TA. Two strategies for qualitative content analysis: an intramethod approach to triangulation. Qualitative Health Research [Internet]. SAGE Publications. 2018;28:824-31.
Williams V, Boylan AM, Nunan D. Critical appraisal of qualitative research: necessity, partialities and the issue of bias. BMJ Evidence-Based Medicine [Internet]. BMJ. 2020;25:9-11. DOI :10.1136/bmjebm-2018-111132
Crispim MAE, Reis MNG, Abrahim C, Kiesslich D, Fraiji N, Bello G, et al. Homogenous HIV-1 subtype B from the Brazilian Amazon with infrequent diverse BF1 recombinants, subtypes F1 and C among blood donors. Chemin I, editor. PLOS ONE [Internet]. Public Library of Science (PLoS). 2019 ;14:e0221151.
Lecher SL, Fonjungo P, Ellenberger D, Toure CA, Alemnji G, Bowen N, et al. HIV viral load monitoring among patients receiving antiretroviral therapy — eight Sub-Saharan Africa Countries, 2013–2018. MMWR Morbidity and Mortality Weekly Report [Internet]. Centers for Disease Control MMWR Office. 2021;70(21): 775–8.
Zeng P, Liu Y, He M, Wang J, Keating S, Mao W, et al. The infection staging and profile of genotypic distribution and drug resistance mutation among the human immunodeficiency virus-1 infected blood donors from five Chinese blood centers, 2012–2014. Lin W, editor. PLOS ONE [Internet]. Public Library of Science (PLoS). 2017 Jun 16;12(6):e0179328. DOI:10.1371/journal.pone.0179328
Hu, Y. Molecular Techniques for Blood and Blood Product Screening. Advanced Techniques in Diagnostic Microbiology 2018 ; 10 : 31–66.
Chow WZ, Bon AH, Keating S, Anderios F, Halim HA, Takebe Y, et al. Extensive genetic diversity of HIV-1 in incident and prevalent infections among Malaysian Blood Donors: Multiple Introductions of HIV-1 Genotypes from Highly Prevalent Countries. Paraskevis D, editor. PLOS ONE [Internet]. Public Library of Science (PLoS). 2016;11(8):e0161853.
Liang S, Liu Z, Wang S, Liu J, Shi L, Mao W, et al. The genotype distribution, infection stage and drug resistance mutation profile of human immunodeficiency virus-1 among the infected blood donors from five Chinese blood centers, 2014–2017. Zhang C, editor. PLOS ONE [Internet]. Public Library of Science (PLoS). 2020 Dec 21;15(12):e0243650.
Aprahamian H, Bish DR, Bish EK. Residual risk and waste in donated blood with pooled nucleic acid testing. Statistics in Medicine, 2016 ; 35 : 5283–5301. Doi:10.1002/sim.7066 .
Van Tienen C, Rugebregt S, Scherbeijn S, Götz H, Geurts van Kessel C. The performance of the Alere HIV combo point-of-care test on stored serum samples; useful for detection of early HIV-1 infections? Sexually Transmitted Infections [Internet]. BMJ. 2017;94(5):331–3. DOI :10.1136/sextrans-2016-052818
Obeng BM, Bonney EY, Asamoah-Akuoko L, Nii-Trebi NI, Mawuli G, Abana CZY, et al. Transmitted drug resistance mutations and subtype diversity amongst HIV-1 sero-positive voluntary blood donors in Accra, Ghana. Virology Journal [Internet]. Springer Science and Business Media LLC. 2020 ;17(1).
Vubil A, Jani VI , Mabunda N, Ismael N, Ramalho D, Morgado MG, et al. Genetic diversity and transmitted drug resistance of HIV-1 subtypes in blood donors candidates in northern mozambique. Journal of AIDS & Clinical Research [Internet]. OMICS Publishing Group. 2016;7(10). DOI:10.4172/2155-6113.1000623
Matsumoto C, Shinohara N, Sobata R, Uchida S, Satake M, Tadokoro K. Genetic Analysis of HIV-1 in Japan: a Comprehensive Analysis of Donated Blood. Japanese Journal of Infectious Diseases [Internet]. Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis; 2017;70(2):136–42.
DOI : 10.7883/yoken.jjid.2015.504
Kiely P, Gambhir M, Cheng AC, McQuilten ZK, Seed CR, Wood EM. Emerging infectious diseases and blood safety: modeling the transfusion-transmission risk. Transfusion Medicine Reviews [Internet]. Elsevier BV. 2017;31(3):154–64. DOI :10.1016/j.tmrv.2017.05.002
Kramer K, Zaaijer HL, Verweij MF. The Precautionary Principle and the Tolerability of Blood Transfusion Risks. The American Journal of Bioethics [Internet]. Informa UK Limited; 2017;17(3):32–43.
Mathur A, Dontula S, Jagannathan L. A study of centralized individual donor nucleic acid testing for transfusion transmitted infections to improve blood safety in Karnataka, India. Glob J Transfus Med 2017 ; 2 : 24-32.
Rocha D, Andrade E, Godoy DT, Fontana-Maurell M, Costa E, Ribeiro M, et al. The Brazilian experience of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in blood donors. Transfusion [Internet]. Wiley; 2018 ;58(4):862-70. Doi.org/10.1111/trf.14478.
Hans R, Marwaha N, Sharma S, Sachdev S, & Sharma RR. Initial trends of individual donation nucleic acid testing in voluntary & replacement donors from a tertiary care centre in north India. Indian J Med Res 2019, 149 : 633-640.
O’Brien SF, Yi QL, Fan W, Scalia V, Goldman M, Fearon MA. Residual risk of HIV, HCV and HBV in Canada. Transfusion and Apheresis Science [Internet]. Elsevier BV. 2017;56(3):389-91.
Dodd RY. Emerging infections and transfusion safety. Practical Transfusion Medicine [Internet]. Wiley. 2017 Mar 10;176-83.
Awan SA, Junaid A, Sheikh S. Transfusion transmissible infections: Maximizing donor surveillance. Cureus [Internet]. Cureus, Inc.; 2018 Dec 28.
Dadzie I, Muniru S, Adu P, Cudjoe O. Nucleic Acid Amplification Testing Detects HIV Transmission Risk in Serologically-Tested Blood Donor Units. Journal of Clinical and Diagnostic Research. 2018;12 :DC22-DC24 .
Waheed U, Noor FA, Saba N, Wazeer A, Qasim Z, Arshad M, et al. Genetic diversity of human immunodeficiency virus type 1 in asymptomatic blood donors in Islamabad, Pakistan. Journal of Laboratory Physicians [Internet]. Georg Thieme Verlag KG. 2020 Aug;12(02):092–7. DOI:10.1055/s-0040-1716593
Vieira PCM, Lamarao LM, Amaral CEM, Correa ASM, Lima MSM, Barile KAS, et al. Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil. Transfusion. 2017 ;57 :1968–1976.
Yooda AP, Sawadogo S, Soubeiga ST, Obiri-Yeboah D, Nebie K, Ouattara AK., … Simpore J. Residual risk of HIV, HCV, and HBV transmission by blood transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina Faso. Journal of Blood Medicine 2019 ; 10 : 53–58.
Dongmo EG, Nsagha DS, Zofou D, Longdoh Njunda A. , Nanfack AJ, Fokam,J & Tayou Tagny, C. Residual risk of HIV transmission through blood transfusion in five blood banks in Cameroon. The Journal of Medical Research 2020 ; 6: 158-165.
Souza JC, Crispim MAE, Abrahim C, Fraiji NA, Kiesslich D, Stefani MMA. High rate of seromarkers for HIV, HBV and syphilis among blood donors using confidential unit exclusion, before and after HIV‐NAT implementation at a major public blood bank in the Brazilian Amazon. Transfusion [Internet]. Wiley; 2018 ;59(2):629–38. DOI:10.1111/trf.15045.
Ghosh K, Misra K. HIV risk associated with nucleic acidtesting tested seronegative blood donation where the donor wasnot preassessed for the risk. Asian Journal of Transfusion Science [Internet]. Medknow. 2017;11(2):213.
Aramani SS, Bommanahalli BP, Kammar SM. Efficacy of Nucleic Acid Amplification Test (NAT) over Enzyme Linked Immuno Sorbent Assay (ELISA) in Detecting Transfusion Transmissible Infections (TTI) among blood donors at a tertiary care centre. Annals of Pathology and Laboratory Medicine [Internet]. Marwah Infotech. 2019 Apr 29;6(4):A244–247. DOI :10.21276/apalm.2453
Mangala C, Fokam J, Maulot-Bangola D, Moundanga M, Nkoa T. Residual risk of HIV in African transfusional setting: Systematic review and meta-analysis. International STD Research & Reviews [Internet]. Sciencedomain International. 2021;25–36.
DOI : 10.9734/isrr/2021/v10i230129
Tee KK, Bon AH, Chow WZ, Ng KT, Chan KG, Kamarulzaman A, et al. Genome Sequence of a Novel HIV-1 Circulating Recombinant Form (CRF77_cpx) Identified among Blood Donors in Malaysia. Genome Announcements [Internet]. American Society for Microbiology; 2017 Jun 29;5(26).
He W, Han X, An M, Hai Y, Chang L, Liu C, et al. Near Full-Length Genome Sequence of a Novel HIV-1 Second-Generation Recombinant Form (CRF01_AE/CRF07_BC) Detected Among Blood Donors in North China. AIDS Research and Human Retroviruses [Internet]. Mary Ann Liebert Inc; 2017 Dec;33(12):1265–9. Doi:10.1089/aid.2017.0111
De Oliveira F, Mourez T, Vessiere A, Ngoupo PA, Alessandri-Gradt E, Simon F, et al. Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon. Retrovirology [Internet]. Springer Science and Business Media LLC. 2017;14(1).
Weimer A, Tagny CT, Tapko JB, Gouws C, Tobian AAR, Ness PM, et al. Blood transfusion safety in sub-Saharan Africa: A literature review of changes and challenges in the 21st century. Transfusion 2019 ; 59 : 412-427.
Ware AD, Jacquot C, Tobian AAR, Gehrie EA, Ness PM, & Bloch EM. Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low-resource settings. Vox Sanguinis 2018 ; 113 : 3-12.
Mishra KK, Trivedi A, Sosa S, Patel K, Ghosh K. NAT positivity in seronegative voluntary blood donors from western India. Transfusion and Apheresis Science. 2017;56:175-178.
Yooda AP, Soubeiga ST, Yacouba Nebie K, Diarra B, Sawadogo S, Ouattara AK, et al. Impact of multiplex PCR in reducing the risk of residual transfusion-transmitted human immunodeficiency and hepatitis B and C viruses in Burkina Faso. Mediterr J Hematol Infect Dis. 2018 ;10:e2018041.
Pawar A, Jagani R, Dimri U, Kumar S. Experience of individual donor nucleic acid testing on screening of blood donors for human immunodeficiency virus, Hepatitis C Virus, and Hepatitis B Virus at an Apex blood bank of Northern India. Medical Journal of Dr DY Patil Vidyapeeth [Internet]. Medknow. 2021;0(0):0.
Lv X, Rodgers MA, Yin P, Ke L, Fu P, Wu B, et al. Molecular surveillance of HIV, HBV, and HCV amongst blood donors in five Chinese regions. Cold Spring Harbor Laboratory; 2020.
Abstract View: 139 times
PDF Download: 51 times